INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Related Keywords

,Reproductive Technology ,Bioscience Inc ,Nasdaq ,Webcast Information ,Investor Relations ,Assisted Reproductive Technology ,Intravaginal Culture ,Vitro Fertilization ,Intrauterine Insemination ,Invo Bioscience ,Nc ,